BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2009
View Archived Issues
Merck KGaA presents novel PDK1 inhibitors with oncolytic properties
Read More
Novel gamma-secretase inhibitors patented by Schering-Plough for treating Alzheimer's disease
Read More
New orexin receptor antagonists imparted by GSK for sleep disorders
Read More
Cyclopamine blocks serous ovarian tumor growth in vivo
Read More
U.S. Department of Health & Human Services divulges new antibacterial PSMalpha peptides
Read More
Oramed completes proof-of-concept study of ORMD-0802
Read More
EGEN-001 with chemotherapy shows activity in ovarian cancer
Read More
Fourth quarter highlights at AstraZeneca
Read More
ImClone continues development of arylphthalazine VEGFR-2 inhibitors
Read More
Cell-based gene therapy effective in SCID due to ADA deficiency
Read More
Fujifilm raises equity stake in Perseus Proteomics to focus on antibody-based therapeutics
Read More
Esteve Teijin Healthcare: A new venture to improve home respiratory therapy
Read More
PharmaMar receives Swiss approval for Yondelis in soft tissue sarcoma
Read More
Tibotec seeks traditional approval from FDA for Intelence
Read More
Cyclacel advances sapacitabine pivotal trial plan in hematological malignancies
Read More
Idenix and GlaxoSmithKline sign worldwide license agreement for IDX-899
Read More
FDA accepts for review NDA for intranasal ROX-888
Read More
Johnson & Johnson presents an update on Invega and paliperidone palmitate
Read More
Tigris files IND for anticancer drug GGTI-2418
Read More
FDA approves ATryn to prevent thromboembolic events
Read More
Nplate approved in the E.U. for the treatment of ITP
Read More
Orexo enters into exclusive development agreement for its OX-17 program
Read More
Daiichi Sankyo returns U.S. and European marketing rights for Collategene to AnGes
Read More
Bayer Schering initiates CHEST-1 and PATENT-1 phase III clinical trials of riociguat
Read More
Inhibitors of HIV reverse transcriptase under development at Yale University
Read More